Eotaxin receptor (CCR3) antagonism in asthma and allergic disease
EM Erin, TJ Williams, PJ Barnes… - Current Drug Targets …, 2002 - ingentaconnect.com
A range of low molecular weight chemicals have been developed to antagonise the eotaxin
receptor, cysteine-cysteine chemokine receptor-3 (CCR3), with the aim of selectively …
receptor, cysteine-cysteine chemokine receptor-3 (CCR3), with the aim of selectively …
Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children
A Zacharasiewicz, N Wilson, C Lex, EM Erin… - American Journal of …, 2005 - atsjournals.org
The use of noninvasive methods of monitoring airway inflammation, such as exhaled nitric
oxide (eNO) and induced sputum, has been shown to improve asthma monitoring and …
oxide (eNO) and induced sputum, has been shown to improve asthma monitoring and …
The effects of a monoclonal antibody directed against tumor necrosis factor-α in asthma
EM Erin, BR Leaker, GC Nicholson, AJ Tan… - American journal of …, 2006 - atsjournals.org
Rationale: Neutralization of tumor necrosis factor-α (TNF-α) is an effective antiinflammatory
therapy for several chronic inflammatory diseases. Methods and Objectives: We undertook a …
therapy for several chronic inflammatory diseases. Methods and Objectives: We undertook a …
A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics
TT Hansel, SA Kharitonov, LE Donnelly… - The FASEB …, 2003 - Wiley Online Library
The inducible isoenzyme of nitric oxide synthase (iNOS) generates nitric oxide (NO) in
inflammatory diseases such as asthma. The prodrug L‐N6‐(1‐iminoethyl) lysine 5‐tetrazole …
inflammatory diseases such as asthma. The prodrug L‐N6‐(1‐iminoethyl) lysine 5‐tetrazole …
Theophylline: mechanism of action and use in asthma and chronic obstructive pulmonary disease.
TT Hansel, RC Tennant, AJ Tan, LA Higgins… - Drugs of Today …, 2004 - europepmc.org
Despite having been recognized for a long time as a cheap and effective therapy for the
treatment of asthma and chronic obstructive pulmonary disease (COPD), theophylline is …
treatment of asthma and chronic obstructive pulmonary disease (COPD), theophylline is …
Long-acting β2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?
RC Tennant, EM Erin, PJ Barnes, TT Hansel - Current opinion in …, 2003 - Elsevier
Bronchodilators are the mainstay of therapy for patients with established chronic obstructive
pulmonary disease (COPD) but, at present, the majority of patients use short-acting agents …
pulmonary disease (COPD) but, at present, the majority of patients use short-acting agents …
Topical corticosteroid inhibits interleukin‐4,‐5 and‐13 in nasal secretions following allergen challenge
EM Erin, AS Zacharasiewicz… - Clinical & …, 2005 - Wiley Online Library
Background Cytokines and chemokines produced by allergen‐reactive T‐helper type 2
(Th2) cells may be pivotal to the pathophysiology of allergic disorders. Objective This study …
(Th2) cells may be pivotal to the pathophysiology of allergic disorders. Objective This study …
Glycopyrrolate causes prolonged bronchoprotection and bronchodilatation in patients with asthma
TT Hansel, H Neighbour, EM Erin, AJ Tan, RC Tennant… - Chest, 2005 - Elsevier
Introduction Inhaled anticholinergic drugs are effective bronchodilators in the treatment of
COPD, and tiotropium bromide has recently been introduced as a once-daily bronchodilator …
COPD, and tiotropium bromide has recently been introduced as a once-daily bronchodilator …
Rapid effect of inhaled ciclesonide in asthma: a randomized, placebo-controlled study
EM Erin, AS Zacharasiewicz, GC Nicholson, AJ Tan… - Chest, 2008 - Elsevier
Background Ciclesonide is a novel inhaled corticosteroid for the treatment of asthma, and it
is important to measure the onset of effect of this therapy on airway hyperresponsiveness …
is important to measure the onset of effect of this therapy on airway hyperresponsiveness …
Single dose topical corticosteroid inhibits IL‐5 and IL‐13 in nasal lavage following grass pollen challenge
EM Erin, BR Leaker, AS Zacharasiewicz, LA Higgins… - Allergy, 2005 - Wiley Online Library
Background: Nasal lavage is a noninvasive method of obtaining inflammatory exudates
following nasal allergen challenge (NAC), and permits cells and released mediators to be …
following nasal allergen challenge (NAC), and permits cells and released mediators to be …